TheraRadar
← Back
Data updated: Mar 29, 2026

PHARMAESSENTIA CORP

OncologyInfectious DiseaseImmunology
Biotech

PHARMAESSENTIA CORP is a biotechnology company focused on Oncology, Infectious Disease, Immunology.

2021
Since
1
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

BESREMI 2024-04-29
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 46%
0 drugs Phase 3: 1 Phase 1: 2
Infectious Disease 46%
0 drugs Phase 3: 1 Phase 1: 2
Immunology 8%
0 drugs Phase 1: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease, Immunology
Merck big-pharma
Oncology, Infectious Disease, Immunology
AbbVie big-pharma
Immunology, Oncology, Infectious Disease
Johnson & Johnson big-pharma
Oncology, Immunology, Infectious Disease
GSK big-pharma
Infectious Disease, Oncology, Immunology